Cardiac amyloidosis
Conditions
Interventions
None listed
Sponsors
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cardiac amyloidosis patients with 1)AL amyloidosis 2)Mutant ATTR amyloidosis 3)Wild type ATTR amyloidosis
Exclusion criteria
Exclusion criteria: A pregnant woman or pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)All cause death | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Cardiovascular death and non cardiovascular death 2) Unplanned hospitalization due to worsening heart failure 3) Exacerbation of symptom 4) Change of treatment strategy 5) Change of laboratory and echocardiographic data | — |
Countries
Japan
Contacts
Public ContactSeiji Takashio
Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine
Outcome results
None listed